Kratom policy: The challenge of balancing therapeutic potential with public safety - Prozialeck, Walter C.; Avery, Bonnie A.; Boyer, Edward W.; Grundmann, Oliver; Henningfield, Jack E.; Kruegel, Andrew C.; McMahon, Lance R.; McCurdy, Christopher R.; Swogger, Marc T.; Veltri, Charles A.; Singh, Darshan (The International journal of drug policy, 2019)
Keywords: Addictions; Animals; Classification; Clinical research; Clinical trials; Drug and Narcotic Control - legislation & jurisprudence; Drug policy; Efficacy; Enforcement; Fatigue; Humans; Ketum; Kratom; Mass media; Mitragyna - adverse effects; Mitragynine; Narcotics; Opioid use disorder (OUD); Opioids; Pain; Pain management; Physicians; Plant Extracts - adverse effects; Plant Extracts - pharmacology; Plant Extracts - therapeutic use; Plant Leaves - adverse effects; Policy making; Public safety; Quality; Quality control; Scientists; Secologanin Tryptamine Alkaloids - adverse effects; Secologanin Tryptamine Alkaloids - pharmacology; Secologanin Tryptamine Alkaloids - therapeutic use; Selfmanagement; Side effects; Substance Withdrawal Syndrome - drug therapy; Symptom management; Withdrawal symptoms; United States--US; Ketum; Drug policy; Opioid use disorder (OUD); Mitragynine; Kratom; Pain management